Description
Arteark-120 (Artesunate Injection IP 120mg): A Reliable Solution for Severe Malaria
When it comes to treating life-threatening malaria infections, especially those caused by Plasmodium falciparum, fast and effective intervention is critical. Arteark-120, formulated with Artesunate Injection IP 120mg, stands out as a trusted anti-malarial injection designed for rapid action in clinical and hospital settings.
Arteark-120 is a high-quality injectable artesunate formulation available in a 10ML vial. It is widely used for the treatment of severe malaria cases where oral medications may not be effective or feasible. Artesunate, a derivative of artemisinin, is globally recognized for its potent and rapid parasite-clearing ability.
Key Benefits of Arteark-120
- Rapid Action: Quickly reduces parasite load in severe infections
- WHO-Recommended Treatment: Preferred choice for severe malaria management
- High Efficacy: Particularly effective against Plasmodium falciparum malaria
- Injectable Form: Ideal for hospitalized patients unable to take oral medication
- Reliable Dosage: 120 mg strength ensures effective therapeutic outcomes
Clinical Applications
Arteark-120 is commonly administered in hospitals for:
- Severe and complicated malaria cases
- Patients with vomiting or unconsciousness
- Emergency malaria treatment protocols
- Cases resistant to conventional oral therapies
Healthcare professionals often prefer Artesunate injections due to their superior safety profile and faster recovery outcomes compared to older anti-malarial drugs.
Dosage and Administration
The dosage of Arteark-120 depends on the patient’s weight and the severity of infection. It is typically administered intravenously (IV) or intramuscularly (IM) under strict medical supervision. Proper reconstitution and administration techniques are essential for optimal results.
Safety and Precautions
While Arteark-120 is generally well-tolerated, it should only be used under medical guidance. Common precautions include:
- Monitoring for allergic reactions
- Adjusting dosage in special populations (children, pregnant women)
- Ensuring sterile handling during injection
Conclusion
Arteark-120 (Artesunate Injection IP 120mg) plays a vital role in modern malaria treatment protocols. With its rapid parasite clearance, strong clinical backing, and ease of administration, it remains a cornerstone in combating severe malaria cases. For hospitals and healthcare providers seeking a reliable injectable anti-malarial drug, Arteark-120 offers both effectiveness and trust.
